Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sensex Today Rallies 762 Points | Nifty Above 24,150 | TCS & Tech Mahindra Top Gainers - Equitymaster
Sensex Today Rallies 762 Points | Nifty Above 24,150 | TCS & Tech Mahindra Top GainersEquitymaster
Sensex Today Rallies 762 Points | Nifty Above 24,150 | TCS & Tech Mahindra Top Gainers - Equitymaster
Sensex Today Rallies 762 Points | Nifty Above 24,150 | TCS & Tech Mahindra Top GainersEquitymaster
Stocks in news: TCS, Groww, Shriram Finance, Dixon Tech, Anand Rathi Wealth
Indian markets saw a rebound on Thursday, recovering from Wednesday's sharp sell-off. TCS reported a 5% year-on-year profit growth, and Groww affirmed its direct mutual fund strategy. Shriram Finance is raising funds to reduce borrowing costs after a rating upgrade. Maruti Suzuki plans to add service points, and Dixon Tech will expand smartphone manufacturing. Premier Energies commissioned a solar module facility, and Anand Rathi Wealth saw profit rise.
Sensex jumps over 500 points, Nifty tops 24,150 as oil slips below $70/bbl on US-Iran peace talks
Indian stock markets saw a second day of gains, with Sensex and Nifty inching up as oil prices plummeted to $70 a barrel amid US-Iran peace talks. Tech stocks like Infosys led the charge, while broader markets also traded higher. Analysts point to falling crude, strong auto sales, and tapering FII selling as positive near-term drivers, though monsoon progress remains a watch point.
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex rises over 150 pts, Nifty above 23,900; M&M, Adani Ports up 2% each - The Economic Times
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex rises over 150 pts, Nifty above 23,900; M&M, Adani Ports up 2% eachThe Economic TimesClosing Bell: Sensex, Nifty end lower in volatile June expiry session; pharma, realty buck trendMoneycontrol.comSensex today | Stock Market Live: Sensex rises 500 pts, Nifty crosses 24,000; KPIT hits 52-week low, tanks 15%BusinessLine
Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%
Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The Sensex surged over 200 points to cross 77,000, while the Nifty 50 also saw a healthy jump, nearing 24,000. Broader market indices, including Midcap and Smallcap, also participated in the upward trend, adding to the positive sentiment.
Bharat Forge, GE Vernova among 10 midcap stocks that hit 52-week highs & rallied up to 20% in a month
The Sensex rose 254 points to close at 77,409 on Thursday, lifting broader markets. Ten BSE 150 MidCap stocks touched fresh 52-week highs, signalling strong investor confidence. GE Vernova T&D India led gains, while banking, infrastructure and industrial stocks also advanced.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
Why top fund managers think foreign investors could return to India
India's market outlook is improving as oil prices ease and geopolitical risks recede. Sunil Singhania, Founder of Abakkus Asset Manager, Prashant Khemka, Founder, Whiteoak Capital and Nilesh Shah, Managing Director at Kotak Mahindra AMC explain why foreign investor sentiment could improve, where earnings growth is strongest, and which sectors—from banks to renewables—offer the most compelling opportunities.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.